Patents expiring in 2030

US 7842729

Anti tubercular drug: compositions and methods

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Nov 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7842704

Compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity

Theravance, Inc. · Granted Tue Nov 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7842717

DNT-maleate and methods of preparation thereof

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Nov 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7842798

Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccines

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7842706

Pharmaceutical composition

Takeda Pharmaceutical Company Limited · Granted Tue Nov 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7846450

Melanoma associated peptide analogues and vaccines against melanoma

UNITED STATES OF AMERICA, AS REPRESENTED BY SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES · Granted Tue Dec 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7846892

Compositions and methods for Alzheimer's disease

Primex Clinical Laboratories, Inc. · Granted Tue Dec 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7847084

VMP-like sequences of pathogenic Borrelia species and strains

The Board of Regents of the University of Texas System · Granted Tue Dec 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7846431

Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases

HALOZYME, INC. · Granted Tue Dec 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7846895

Selectively targeted antimicrobial peptides and the use thereof

The Regents of the University of California · Granted Tue Dec 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7846945

Piperdine-based inhibitors of sodium glucose co-transporter 2 and methods of their use

LEXICON PHARMACEUTICALS, INC. · Granted Tue Dec 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7846907

Double-stranded RNA (dsRNA) and method of use for inhibiting expression of a fusion gene

Alnylam Pharmaceuticals, Inc. · Granted Tue Dec 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7846903

Type II cubic liquid crystal composition

KURARAY CO., LTD. · Granted Tue Dec 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7846675

Truncated recombinant major outer membrane protein antigen (R56) of orientia tsutsugamushi strains karp, kato and gilliam and its use in antibody based detection assays and vaccines

United States of America as represented by the Secretary of the Air Force · Granted Tue Dec 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7846664

Diagnosis and treatment of chronic lymphocytic leukemia (CLL)

The Regents of the University of California · Granted Tue Dec 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7846466

Biodegradable scaffolds and uses thereof

Northwestern University · Granted Tue Dec 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7846954

Heterocyclic derivatives as modulators of ion channels

Vertex Pharmaceuticals Incorporated · Granted Tue Dec 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7846426

Compositions and methods for treating and preventing cardiomyopathy and heart disease

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Dec 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7846951

Thiazoles and oxazoles useful as modulators of ATP-binding cassette transporters

Vertex Pharmaceuticals Incorporated · Granted Tue Dec 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7846454

Cloned genomes of infectious hepatitis C viruses and uses thereof

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7846455

Attenuated chimeric respiratory syncytial virus

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7846690

Cloning of honey bee allergen

PLS-Design GmbH · Granted Tue Dec 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7846973

Chemical process and new crystalline form

Theravance, Inc. · Granted Tue Dec 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7846955

Salt

Argenta Discovery Limited · Granted Tue Dec 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7846908

RNAi modulation of TGF-beta and therapeutic uses thereof

Alnylam Pharmaceuticals, Inc. · Granted Tue Dec 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

EP 2257267

WIRKSTOFFKOMBINATION UND IHRE VERWENDUNG

AIR LIQUIDE SANTE INT [FR] · Granted Wed Dec 08 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue Dec 03 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7851449

Peptide, pharmaceutical composition, and a method of treating microcirculation disorders

Obschestvo S Ogranichennoi Otvetstvennostyu “Sia Peptides” · Granted Tue Dec 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7851465

Compositions and methods relating to novel compounds and targets thereof

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Dec 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7851445

Angiogenic heparin-binding epitopes, peptide amphiphiles, self-assembled compositions and related methods of use

Northwestern University · Granted Tue Dec 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7851169

Compositions and methods for inhibiting squamous cell carcinoma

The United States of America as represented by the Department of Veterans Affairs Office of the General Counsel · Granted Tue Dec 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7850970

Inhibitors of serine protease activity and their use in methods and compositions for treatment of bacterial infections

The Regents of the University of Colorado · Granted Tue Dec 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7851632

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. · Granted Tue Dec 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7850961

Methods for targeting solid tumor stem cells in a solid tumor using a notch4 receptor antagonist

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Dec 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7851506

Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy

Jazz Pharmaceuticals, Inc. · Granted Tue Dec 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7851565

Stabilized polymeric thiol reagents

Nektar Therapeutics · Granted Tue Dec 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7851631

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. · Granted Tue Dec 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7851495

Thiophene-carboxamides useful as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated · Granted Tue Dec 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7851194

West Nile viruses with mutations in the 3′ terminal stem and loop secondary structure for use as live virus vaccines

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7851480

Spiro 2,4-pyrimidinediamine compounds and their uses

Rigel Pharmaceuticals, Inc. · Granted Tue Dec 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7851473

Amide compound

Takeda Pharmaceutical Company Limited · Granted Tue Dec 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7851467

Carbamate compounds as 5-HT4 receptor agonists

Theravance, Inc. · Granted Tue Dec 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7851228

Methods for screening agents that modulate presenilin activity and A-β production

The Regents of the University of California · Granted Tue Dec 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7854932

Immunogenic compositions comprising progastrin and uses thereof

The Board of Regents of the University of Texas System · Granted Tue Dec 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7855291

Process for the preparation of substituted phenylalanines

LEXICON PHARMACEUTICALS, INC. · Granted Tue Dec 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7855221

Crystalline form of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid

Theravance, Inc. · Granted Tue Dec 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7855214

Fused cyclic systems useful as inhibitors of TEC family protein kinases

Vertex Pharmaceuticals Incorporated · Granted Tue Dec 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7855076

Use of discoidin domain receptor 1 (DDR1) and agents that affect the DDR1/collagen pathway

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7855176

Reduced volume formulation of glatiramer acetate and methods of administration

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Dec 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)